BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32430175)

  • 1. Lupeol suppresses plasminogen activator inhibitor-1-mediated macrophage recruitment and attenuates M2 macrophage polarization.
    Park HJ; Chi GY; Choi YH; Park SH
    Biochem Biophys Res Commun; 2020 Jul; 527(4):889-895. PubMed ID: 32430175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The root bark of Morus alba L. regulates tumor-associated macrophages by blocking recruitment and M2 polarization of macrophages.
    Park HJ; Chi GY; Choi YH; Park SH
    Phytother Res; 2020 Dec; 34(12):3333-3344. PubMed ID: 32677743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupeol Counteracts the Proinflammatory Signalling Triggered in Macrophages by 7-Keto-Cholesterol: New Perspectives in the Therapy of Atherosclerosis.
    Saha S; Profumo E; Togna AR; Riganò R; Saso L; Buttari B
    Oxid Med Cell Longev; 2020; 2020():1232816. PubMed ID: 33062133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F1 fraction isolated from Mesobuthus eupeus scorpion venom induces macrophage polarization toward M1 phenotype and exerts anti-tumoral effects on the CT26 tumor cell line.
    Sadeghi M; Amari A; Asadirad A; Nemati M; Khodadadi A
    Int Immunopharmacol; 2024 May; 132():111960. PubMed ID: 38554440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
    Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
    Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage.
    Meng Z; Zhang R; Wang Y; Zhu G; Jin T; Li C; Zhang S
    Int Immunopharmacol; 2020 Apr; 81():106028. PubMed ID: 31801690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.
    Yan X; Li W; Pan L; Fu E; Xie Y; Chen M; Mu D
    J Cell Biochem; 2016 May; 117(5):1158-66. PubMed ID: 26447454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethyl Acetate Fraction of
    Park SH
    J Pharmacopuncture; 2019 Dec; 22(4):253-259. PubMed ID: 31970023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
    Tariq M; Zhang JQ; Liang GK; He QJ; Ding L; Yang B
    Acta Pharmacol Sin; 2017 Nov; 38(11):1501-1511. PubMed ID: 29022575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer.
    Kubala MH; Punj V; Placencio-Hickok VR; Fang H; Fernandez GE; Sposto R; DeClerck YA
    Cell Rep; 2018 Nov; 25(8):2177-2191.e7. PubMed ID: 30463014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen Activator Inhibitor 1 Promotes Immunosuppression in Human Non-Small Cell Lung Cancers by Enhancing TGF-Β1 Expression in Macrophage.
    Zhu C; Shen H; Zhu L; Zhao F; Shu Y
    Cell Physiol Biochem; 2017; 44(6):2201-2211. PubMed ID: 29253845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
    Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy.
    Baumeier C; Escher F; Aleshcheva G; Pietsch H; Schultheiss HP
    Basic Res Cardiol; 2021 Jan; 116(1):1. PubMed ID: 33432417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.
    Xu F; Cui WQ; Wei Y; Cui J; Qiu J; Hu LL; Gong WY; Dong JC; Liu BJ
    J Exp Clin Cancer Res; 2018 Aug; 37(1):207. PubMed ID: 30157903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
    Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
    J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
    Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
    Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupeol inhibits LPS-induced NF-kappa B signaling in intestinal epithelial cells and macrophages, and attenuates acute and chronic murine colitis.
    Lee C; Lee JW; Seo JY; Hwang SW; Im JP; Kim JS
    Life Sci; 2016 Feb; 146():100-8. PubMed ID: 26767626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling.
    Cheng Y; Zhong X; Nie X; Gu H; Wu X; Li R; Wu Y; Lv K; Leung GP; Fu C; Lee SM; Zhang J; Li J
    Phytomedicine; 2023 Jun; 114():154757. PubMed ID: 37011418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.